AYTU BIOPHARMA, INC Other Selling, General and Administrative Expense
AYTU BIOPHARMA, INC (AYTU) reported Other Selling, General and Administrative Expense of $4.62 million for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherSellingGeneralAndAdministrativeExpense · last filed 2017-11-09
- AYTU BIOPHARMA, INC other selling, general and administrative expense for the quarter ending 2017-09-30 was $4.62M, a 19.04% decline year-over-year.
- AYTU BIOPHARMA, INC other selling, general and administrative expense for the quarter ending 2016-09-30 was $5.70M.
| Period end | Other Selling, General and Administrative Expense 3 month |
|---|---|
| 2017-09-30 | $4.62M 10-Q · filed 2017-11-09 |
| 2016-09-30 | $5.70M 10-Q · filed 2017-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |